Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
View of Novel Breast Cancer Treatment by Targeting Estrogen Receptor-Alpha Stability Using Proteolysis-Targeting Chimeras (PROTACs) Technology | Exon Publications
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Dynamic transcriptional events mediated by estrogen receptor alpha
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
An overview on Estrogen receptors signaling and its ligands in breast cancer - ScienceDirect
Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer - Liu - 2020 - Journal of Cellular Biochemistry - Wiley Online Library
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)